Literature DB >> 29216391

Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population.

José Haba-Rubio1, Birgit Frauscher2, Pedro Marques-Vidal3, Jérôme Toriel1, Nadia Tobback1, Daniela Andries1, Martin Preisig4, Peter Vollenweider3, Ronald Postuma5, Raphaël Heinzer1,6.   

Abstract

STUDY
OBJECTIVES: Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia associated with neurodegenerative synucleinopathies. Its prevalence is largely unknown. This study determined the prevalence and characteristics of RBD in the general population using gold-standard polysomnography.
METHODS: Full polysomnographic data from 1,997 participants (age = 59 ± 11.1 years, 53.6% women) participating in a population-based study (HypnoLaus, Lausanne, Switzerland) were collected. Sleep-related complaints and habits were investigated using various sleep measures including the Munich Parasomnia Screening (MUPS) questionnaire, which includes two questions evaluating complex motor behaviors suggestive of RBD. Full polysomnography was performed at home. For participants screening positive for RBD, muscle activity during REM sleep was quantified to diagnose RBD.
RESULTS: Three hundred sixty-eight participants endorsed dream-enactment behavior on either of the two MUPS questions, and 21 fulfilled polysomnographic criteria for RBD, resulting in an estimated prevalence of 1.06% (95% CI = 0.61-1.50), with no difference between men and women. Compared with RBD- participants, RBD+ took more frequently antidepressants and antipsychotics (23.8% vs. 5.4%, p = .005; 14.3% vs. 1.5%, p = .004, respectively) and were more frequently smokers or ex-smokers (85% vs. 56.6%, p = .011). On polysomnography, RBD+ had more stage N2 sleep (52 ± 11.5% vs. 46.3 ± 10.2%, p = .024) and less REM sleep (18 ± 6.4% vs. 21.9 ± 6.2%, p = .007), lower apnea-hypopnea index in REM sleep (3.8 ± 5.2 vs. 8.9 ± 13/hour, p = .035), and lower autonomic arousal index (31 ± 14.9 vs. 42.6 ± 19.5/hour, p = .002).
CONCLUSIONS: In our middle-to-older age population-based sample, the prevalence of RBD was 1.06%, with no difference between men and women. RBD was associated with antidepressant and antipsychotic use and with minor differences in sleep structure. © Sleep Research Society 2017. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  REM sleep without atonia; parasomnia; polysomnography; sleep; synucleinopathies

Year:  2018        PMID: 29216391     DOI: 10.1093/sleep/zsx197

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  38 in total

1.  Prognostic Counseling for Patients With Idiopathic/Isolated REM Sleep Behavior Disorder: Should We Tell Them What's Coming? Yes.

Authors:  Erik K St Louis
Journal:  Mov Disord Clin Pract       Date:  2019-10-01

2.  REM sleep without atonia is associated with increased rigidity in patients with mild to moderate Parkinson's disease.

Authors:  Maria E Linn-Evans; Matthew N Petrucci; Sommer L Amundsen Huffmaster; Jae Woo Chung; Paul J Tuite; Michael J Howell; Aleksandar Videnovic; Colum D MacKinnon
Journal:  Clin Neurophysiol       Date:  2020-05-12       Impact factor: 3.708

3.  Factors Influencing the Presentation of REM Sleep Behavior Disorder: The Relative Importance of Sex, Associated Neurological Disorder, and Context of Referral to Polysomnography.

Authors:  Paulo Bugalho; Manuel Salavisa
Journal:  J Clin Sleep Med       Date:  2019-11-05       Impact factor: 4.062

Review 4.  Clinical trials in REM sleep behavioural disorder: challenges and opportunities.

Authors:  Aleksandar Videnovic; Yo-El S Ju; Isabelle Arnulf; Valérie Cochen-De Cock; Birgit Högl; Dieter Kunz; Federica Provini; Pietro-Luca Ratti; Mya C Schiess; Carlos H Schenck; Claudia Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-05-13       Impact factor: 10.154

Review 5.  Lewy Body Degenerations as Neuropsychiatric Disorders.

Authors:  Jared T Hinkle; Gregory M Pontone
Journal:  Psychiatr Clin North Am       Date:  2020-04-08

6.  Risk factors for possible REM sleep behavior disorders: A community-based study in Beijing.

Authors:  Hui Zhang; Zhuqin Gu; Chun Yao; Yanning Cai; Yuan Li; Wei Mao; Erhe Xu; Ronald B Postuma; Piu Chan
Journal:  Neurology       Date:  2020-08-11       Impact factor: 9.910

7.  Posttraumatic stress disorder increases the odds of REM sleep behavior disorder and other parasomnias in Veterans with and without comorbid traumatic brain injury.

Authors:  Jonathan E Elliott; Ryan A Opel; Dennis Pleshakov; Tara Rachakonda; Alexander Q Chau; Kristianna B Weymann; Miranda M Lim
Journal:  Sleep       Date:  2020-03-12       Impact factor: 5.849

8.  Olfactory Testing in Parkinson Disease and REM Behavior Disorder: A Machine Learning Approach.

Authors:  Christine Lo; Siddharth Arora; Yoav Ben-Shlomo; Thomas R Barber; Michael Lawton; Johannes C Klein; Sofia Kanavou; Annette Janzen; Elisabeth Sittig; Wolfgang H Oertel; Donald G Grosset; Michele T Hu
Journal:  Neurology       Date:  2021-02-24       Impact factor: 9.910

9.  Prevalence of isolated RBD in the city of Catania, Italy: a population-based study.

Authors:  Calogero Edoardo Cicero; Loretta Giuliano; Riccardo Sgroi; Raffaele Squillaci; Claudio Terravecchia; Edoardo Vancheri; Valeria Todaro; Paola Reitano; Sofia Rizzo; Antonina Luca; Giovanni Mostile; Vincenza Paradisi; Mario Zappia; Alessandra Nicoletti
Journal:  J Clin Sleep Med       Date:  2021-11-01       Impact factor: 4.062

10.  Association of probable REM sleep behavior disorder with pathology and years of contact sports play in chronic traumatic encephalopathy.

Authors:  Jason W Adams; Michael L Alosco; Jesse Mez; Victor E Alvarez; Bertrand R Huber; Yorghos Tripodis; Charles H Adler; Carol Kubilius; Kerry A Cormier; Rebecca Mathais; Raymond Nicks; Hunter J Kelley; Nicole Saltiel; Madeline Uretsky; Evan Nair; Nurgul Aytan; Jonathan D Cherry; Christopher J Nowinski; Neil W Kowall; Lee E Goldstein; Brigid Dwyer; Douglas I Katz; Robert C Cantu; Robert A Stern; Ann C McKee; Thor D Stein
Journal:  Acta Neuropathol       Date:  2020-09-17       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.